August 1, 2022

Stelara Now Indicated for Psoriatic Arthritis in Children

Read More
July 31, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Read More
July 29, 2022

Rebinyn Approved to Prevent Hemophilia B Bleeding Episodes

Read More
July 29, 2022

New Topical Medication Zoryve Approved for Plaque Psoriasis

Read More
July 26, 2022

Benlysta Approved for Younger Lupus Nephritis Patients

Read More
July 19, 2022

FDA Approves First Therapy for Repigmentation in Vitiligo

Read More
July 15, 2022

Zonisade Approved to Treat Seizures

Read More
July 14, 2022

Xalkori Granted New Indication to Treat Non-Cancerous Tumors

Read More
July 14, 2022

Diacomit Approved for Broader Age Group

Read More
July 8, 2022

Krystexxa Approved for Use with Methotrexate

Read More